8-K: MultiPlan Corporation Faces NYSE Delisting Threat After Share Price Falls Below $1

MultiPlan Corporation received a notice from the New York Stock Exchange for non-compliance with listing standards due to its stock price falling below $1.00.

Summary

• MultiPlan Corporation received a notice from the New York Stock Exchange (NYSE) on March 28, 2024, stating that the company is not in compliance with the continued listing standard because its average share price was below $1.00 for 30 consecutive trading days.
• The company has six months to regain compliance, which requires the stock to close at or above $1.00 on the last trading day of any month during the cure period and maintain an average closing price of at least $1.00 over the preceding 30 trading days.
• If MultiPlan fails to meet these requirements within the six-month period, the NYSE will initiate procedures to suspend and delist the company's stock.
• MultiPlan intends to respond to the NYSE within ten business days and is considering options such as a reverse stock split, subject to shareholder approval by September 28, 2024, to regain compliance.
• The notice does not immediately affect the listing of the company's stock, which will continue to trade on the NYSE during the cure period.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and the company's stock price falling below $1.00. While the company intends to regain compliance, the situation creates uncertainty and potential risk for investors.

Positives

• The notice has no immediate impact on the listing of MultiPlan's stock, which will continue to trade on the NYSE during the cure period.
• The notice does not affect the company's business operations or its reporting obligations with the Securities and Exchange Commission.
• The company intends to regain compliance and will take necessary action to ensure that the Common Stock continues to be listed on the NYSE.
• MultiPlan remains focused on executing its Growth Plan and on delivering results and shareholder value.

Negatives

• MultiPlan's stock price has fallen below the minimum threshold required for continued listing on the NYSE.
• The company faces potential delisting if it fails to regain compliance within six months.
• The company's stock price has been below $1.00 for a sustained period of 30 trading days.

Risks

• There is a risk of delisting from the NYSE if the company fails to regain compliance within the six-month cure period.
• The NYSE can take accelerated delisting action if it determines that the stock trades at abnormally low levels.
• The company's stock price may be negatively impacted by the delisting notice and the uncertainty surrounding its future listing status.
• The company may need to implement a reverse stock split, which could further impact the stock price and shareholder value.

Future Outlook

MultiPlan intends to regain compliance with the NYSE listing standards and is considering a reverse stock split, subject to shareholder approval, as a potential solution. The company remains focused on executing its Growth Plan and delivering shareholder value.

Management Comments

• The Company intends to respond to the NYSE within ten business days of receipt of the Notice with respect to its intent to cure the deficiency.
• The Company also intends to consider available alternatives, including, but not limited to, a reverse stock split, subject to stockholder approval no later than September 28, 2024, if necessary, to regain compliance.
• The Company remains focused on executing its Growth Plan and on delivering results and shareholder value.

Industry Context

This announcement highlights the challenges faced by companies with declining stock prices and the importance of maintaining compliance with exchange listing standards. It is not uncommon for companies to face delisting threats when their stock price falls below a certain threshold, and they often resort to measures like reverse stock splits to regain compliance.

Comparison to Industry Standards

• Many companies listed on major exchanges like the NYSE must maintain a minimum share price to avoid delisting.
• A common threshold is a $1.00 minimum share price, and companies falling below this level are often given a grace period to regain compliance.
• Reverse stock splits are a common mechanism used by companies to increase their share price and meet listing requirements, although they can be viewed negatively by investors.
• Other companies that have faced similar delisting notices include [hypothetical company A] and [hypothetical company B], both of which implemented reverse stock splits to regain compliance.

Stakeholder Impact

• Shareholders face the risk of potential delisting and further stock price decline.
• Employees may experience uncertainty due to the company's financial challenges.
• Customers and suppliers may be concerned about the company's long-term viability.

Next Steps

• MultiPlan will respond to the NYSE within ten business days regarding its plan to cure the deficiency.
• The company will consider a reverse stock split, subject to shareholder approval by September 28, 2024.
• MultiPlan will continue to operate and trade on the NYSE during the six-month cure period.

Key Dates

Keywords

delisting, NYSE, stock price, compliance, reverse stock split, listing standards, share price, MultiPlan